scholarly article | Q13442814 |
P2093 | author name string | Paul Y Kim | |
Michael E Nesheim | |||
P2860 | cites work | The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin | Q66923212 |
Phospholipid-binding properties of bovine factor V and factor Va | Q66938908 | ||
The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C | Q67546959 | ||
Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit | Q67987635 | ||
Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity | Q68041007 | ||
The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system | Q68358930 | ||
Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection | Q70061814 | ||
Factor V | Q70233554 | ||
Regulation of bovine activated protein C by protein S: the role of the cofactor protein in species specificity | Q70559191 | ||
Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V | Q71099927 | ||
Functional properties of human factor Va lacking the Asp683-Arg709 domain of the heavy chain | Q72108255 | ||
Contribution of the heavy and light chains of factor Va to the interaction with factor Xa | Q72520628 | ||
Role of the membrane in the inactivation of factor Va by activated protein C | Q72661630 | ||
Activated protein C cleavage of factor Va leads to dissociation of the A2 domain | Q73575454 | ||
Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site | Q74578461 | ||
The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase | Q80838396 | ||
Factor V: a combination of Dr Jekyll and Mr Hyde | Q28209649 | ||
The mechanism of inactivation of human factor V and human factor Va by activated protein C | Q28242588 | ||
The contribution of bovine Factor V and Factor Va to the activity of prothrombinase | Q28249212 | ||
Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C | Q28275580 | ||
The molecular basis of blood coagulation | Q28294854 | ||
The binding of activated protein C to factors V and Va | Q28304170 | ||
Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism | Q28305220 | ||
Endothelial cell protein C receptor plays an important role in protein C activation in vivo | Q28628837 | ||
Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C | Q28631087 | ||
The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin | Q31905183 | ||
Factor V and thrombotic disease: description of a janus-faced protein | Q34123469 | ||
Anticoagulant properties of bovine plasma protein C following activation by thrombin | Q34241254 | ||
Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. | Q34360006 | ||
Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. | Q36280112 | ||
Exosites in the substrate specificity of blood coagulation reactions | Q36884329 | ||
Surface-dependent reactions in the propagation phase of blood coagulation | Q37711773 | ||
Proexosite-1 on Prothrombin Is a Factor Va-dependent Recognition Site for the Prothrombinase Complex | Q40647381 | ||
Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide | Q41482286 | ||
Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va. | Q44411439 | ||
Structural requirements for expression of factor Va activity | Q44467155 | ||
Binding site for blood coagulation factor Xa involving residues 311-325 in factor Va. | Q44798012 | ||
Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complex | Q45032492 | ||
Factor Va residues 311-325 represent an activated protein C binding region | Q46162373 | ||
Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va. | Q46806167 | ||
Differences in prethrombin-1 activation with human or bovine factor Va can be attributed to the heavy chain. | Q53367354 | ||
Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C. | Q53425306 | ||
Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin. | Q53473754 | ||
A control switch for prothrombinase: characterization of a hirudin-like pentapeptide from the COOH terminus of factor Va heavy chain that regulates the rate and pathway for prothrombin activation. | Q53595426 | ||
Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va. | Q53602924 | ||
P433 | issue | 1 | |
P921 | main subject | drotrecogin alfa | Q412888 |
P304 | page(s) | 61-70 | |
P577 | publication date | 2010-04-13 | |
P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
P1476 | title | Down regulation of prothrombinase by activated protein C during prothrombin activation | |
P478 | volume | 104 |
Q33748551 | Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy |
Q64121883 | Identification and characterization of a factor Va-binding site on human prothrombin fragment 2 |
Q34274796 | Modeling of human factor Va inactivation by activated protein C. |
Search more.